SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: arnie h who wrote (874)8/18/1999 11:35:00 PM
From: Carson O. Ray, Jr.  Read Replies (2) of 1386
 
<Regardless of how good early results are for a new drug candidate, it is not easy to work out the kind of deal with big pharma many people on this thread, and perhaps management, have been expecting (here's a lot of money and a fat royalty plus we'll do all the work). This is especially so when the small company is cash constrained>

Amen to that. Refer to IMGN for a very similar situation.
(I owned PARS 97/98 & sold for a nice profit; looks like a good time to get back in at orig. price.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext